The uptake in vivo of chylomicrons and fl-migrating very-low-density lipoprotein (f8-VLDL) by rat liver, which is primarily carried out by parenchymal cells, is inhibited, 5 min after injection, to respectively 35 and 8 % of the control values after preinjection of lactoferrin. The decrease in the uptake of lipoproteins by the liver caused by lactoferrin is a specific inhibition of uptake by parenchymal cells. Competition studies in vitro demonstrate that chylomicron remnants and ,-VLDL compete for the same recognition site on parenchymal cells. Data obtained in vivo together with the competition studies performed in vitro indicate that chylomicron remnants and /3-VLDL interact specifically with the same remnant receptor. Hepatic uptake of '25I-labelled-a -macroglobulin in vivo, mediated equally by parenchymal and endothelial cells, is not decreased by preinjection of lactoferrin and no effect on the parenchymal-cell-mediated uptake is found. In vitro, a2-macroglobulin and chylomicron remnants or /3-VLDL show no cross-competition. Culturing of parenchymal cells for 24-48 h leads to a decrease in the cell association of a2-macroglobulin to 26 % of the initial value, while the cell association of ,3-VLDL with the remnant receptor is not influenced. It is concluded that fl-VLDL and chylomicron remnants are recognized by a specific remnant receptor on parenchymal liver cells, while uptake of a2-macroglobulin by liver is carried out by a specific receptor system (presumably involving the LDL-receptor-related protein) which shows properties that are distinct from those of the remnant receptor.
INTRODUCTION
Chylomicrons are relatively large triacylglycerol-rich lipoproteins which transport exogenous lipids. Interaction of chylomicrons with endothelial cell-bound lipoprotein lipase and high-density lipoprotein (HDL) results in the formation of chylomicron remnants. This lipoprotein is relatively depleted of triacylglycerols and phospholipids and enriched with cholesterol, cholesterol esters and protein (Mj0s et al., 1975; Redgrave & Small, 1979) . Remnants are rapidly cleared by the liver and uptake is predominantly carried out by parenchymal cells (Groot et al., 1981; Blomhoff et al., 1982 Blomhoff et al., , 1985 Jones et al., 1984) . As shown by studies in patients with type II hyperlipoproteinaemia (Hoeg et al., 1985) and in WHHL rabbits (Kita et al., 1982) , which both possess genetically defective low-density lipoprotein (LDL) receptors, uptake of chylomicron remnants proceeds normally, leading to the conclusion that a receptor system distinct from the LDL receptor, tentatively called the remnant receptor, must be resposible for the avid uptake by liver.
The recognition site for chylomicron remnants differs from the classic LDL receptor (Brown & Goldstein, 1986) in being resistant to regulation (Arbeeny & Rifici, 1984; Krempler et al., 1987) , independent of Ca2+ and recognizing only apolipoprotein E (apoE) and not apoB (Cooper et al., 1982; Krempler et al., 1987) . f-Migrating very-low-density lipoproteins (fl-VLDL) are cholesterol-enriched lipoproteins which accumulate in the plasma of patients with type III hyperlipoproteinaemia and cholesterolfed animals (Frederikson et al., 1969; Shore et al., 1974; Mahley & Holcombe, 1977) . Like chylomicron remnants, ,-VLDL is rapidly cleared by liver parenchymal cells (Harkes et al., 1989) . Studies with ,-VLDL in vitro indicate that uptake of this lipoprotein by macrophages of human and mouse origin is mediated by an (unusual) LDL receptor (Koo et al., 1986; Ellsworth et al., 1987) . Rat liver parenchymal cells hardly express active LDL receptors at all (Harkes & van Berkel, 1984a,b) and, because the specific fl-VLDL interaction with parenchymal cells is not blocked by an excess of LDL, we concluded that, in rats, fl-VLDL is cleared from the blood circulation by the remnant receptor (Harkes et al., 1989) .
Lactoferrin, an Mr-76 500 glycoprotein, possesses a cluster of four arginine residues at the N-terminus, just like the argininerich domain of apoE. Recently, lactoferrin was shown to inhibit the uptake of 125I-labelled chylomicron remnants by whole liver by 50 % (Huettinger et al., 1988) . In the present study we used lactoferrin as a competitor in order to analyse the relationship between uptake sites for chylomicrons and fl-VLDL in rat liver in vivo. The molecular nature of the remnant receptor is under intensive investigation (Herz et al., 1988; Kowal et al., 1989 Kowal et al., , 1990 Jaeckle et al., 1989; Lund et al., 1989; Strickland et al., 1990; Beisiegel et al., 1989) . Herz et al. (1988) identified a 500 kDa protein, the structure of which is closely related to that of the LDL receptor [LDL-receptor-related protein (LRP) ] and suggested that this protein may function as a remnant receptor. Subsequently Kowal et al. (1989 ), Lund et al. (1989 ) and Beisiegel et al. (1989 Vol. 279
receptor (Strickland et al., 1990) showed protein sequence homologies and it was concluded that LRP and thea2-macroglobulin receptor are the same molecule. In the present study we looked simultaneously at the chylomicron//1-VLDL and a2-macroglobulin interactions with the liver in order to analyse directly to what extent the lipoprotein-uptake mechanism can be performed by the LRP/a2-macroglobulin system.
MATERIALS AND METHODS

Chemicals
Collagenase types A and D (EC 3.4.24.3), Pronase, cholesterol esterase (EC 3.1.1.13) and foetal calf serum were from Boehringer-Mannheim. Benzamidine, phenylmethanesulphonyl fluoride and polyethylene were from Merck. BSA (fraction V), 17a-ethinyloestradiol, heparin (sodium salt, grade I) and 3,3'-diaminobenzidine were from Sigma. Human lactoferrin was from Serva. Metrizamide was obtained from Nycomed A/S, Oslo, Norway. Culture media were from Gibco. 4-Aminopyrazolo[3,4-djpyrimidine was from Janssen, Beerse, Belgium.
1251 (carrier-free) in NaOH and-3 H-labelled vitamin A were from Amersham. DEAE-Sepharose fast flow, Sephacryl S-300 Superfine, metal-chelating Sepharose fast flow and Mono Q were from Pharmacia. All other chemicals were of analytical grade.
Animals
Male Wistar rats of mass 225-300 g, fed ad libitum with regular chow, were used in this study. For determination of liver uptake and serum decay, rats were starved for 16 h. For isolation of,-VLDL, six to eight rats of mass 200-220 g were maintained for 16 days on a cholesterol-rich chow (Hope Farms, Woerden, The Netherlands) which included 2% (w/w) cholesterol, 5 % (w/w) olive oil and 0.5 % (w/w) cholic acid. When indicated, 17a-ethinyloestradiol in propylene glycol at a dose of 5 mg/kg body weight (Chao et al., 1979) was injected subcutaneously every 24 h for 3 days. Rats were used 72 h after the first treatment.
Lipoproteins anda2-macroglobulin
Chylomicrons were isolated from rat lymph, obtained via cannulation of the thoracic duct. Briefly, rats were anaesthetized with diethyl ether and the main intestinal lymph duct was cannulated with silastic tubing (external diameter 0.06 cm, internal diameter 0.03 cm). The duodenum was cannulated and rats were placed in restraining cages. A lipid emulsion (Intralipid; Vitrum, Stockholm, Sweden; supplemented with 1 % cholesterol) was infused through the intestinal tubing at a rate of 1.2-1.5 ml/h. At 4 h after surgery, lymph was collected on ice in a plastic tube containing 0.1 ml of 0.1 M-EDTA. Chylomicrons were isolated from rat lymph by ultracentrifugation for 1 h at 40000 rev./min in a Beckman SW40 rotor at 4°C, washed three times with 8 mM-phosphate-buffered saline (PBS) containing 1 mM-EDTA, pH 7.4.
For isolation of 3H-labelled vitamin A-labelled chylomicrons, 2 ml of the lipid emulsion, supplemented with 1 % (w/v) cholesterol, was mixed with solvent-free 3H-labelled vitamin A (0.3 mCi) (Blomhoff et al., 1985) . At 4 h after surgery, the radioactive lipid emulsion was infused into the rats and lymph was isolated as described above.
Remnants were isolated from functionally hepatectomized rats (Redgrave, 1970; Mj0s et al., 1975 injected intraperitoneally (Groot etal., 1981 fl-VLDL was obtained from rats that were starved for 20 h and blood was collected by puncture of the abdominal aorta. The sera were pooled and fl-VLDL was isolated as described (Harkes etal., 1989) .
Human LDL (1.019 < d < 1.063) was isolated from starved human serum by two repetitive centrifugations according to the procedure of Redgrave et al. (1975) . LDL was removed by tube slicing and was free of apoE (Harkes etal., 1989 At the indicated times, liver lobules were excised, weighed and radioactivity was counted. In the case of 3H-labelled vitamin A label, liver and tissue samples were burned in a Packard TriCarb 306 sample oxidizer; this always yielded a recovery of > 97 % label. At the end of the experiment the remainder of the liver was removed, weighed and radioactivity was determined.
The amount of liver tissue tied off at the end of the experiment did not exceed 15 % of the total liver weight. Radioactivity was corrected for the radioactivity in plasma assumed to be present in the tissue at the time of sampling (85 ,ul/g wet weight) (Caster et al., 1955) .
Isolation of liver cells
Rats were anaesthetized and injected with the radiolabelled (lipo)protein. If indicated, rats received an injection of lactoferrin (70 mg/kg body weight) into the bloodstream 1 min before injection of (lipo)proteins. Rat liver parenchymal, endothelial and Kupffer cells were isolated by differential centrifugation and counterflow elutriation as described in detail elsewhere (van Berkel et al., 1987) . The contributions of the different liver cell types to the uptake of (lipo)proteins were determined with the assumption that 92.5 % of total liver protein obtained was from parenchymal cells, 3.3 % from endothelial cells and 2.5 % from Kupffer cells (Blouin et al., 1977; Nagelkerke et al., 1983) .
Kupffer and endothelial cells were more than 950% pure, as judged from peroxidase staining [0.1 0% 3,3'-diaminobenzidine in 0.05 M-Tris/HCI, 7 % (w/v) sucrose, 0.03 % (v/v) H202, pH 7.4; 20 min at 37 0C].
For studies in vitro, parenchymal liver cells were isolated by perfusion of the liver with 0.1 % collagenase (type D) by the method of Seglen (1976) modified as previously described (Casteleijn et al., 1986) . The parenchymal cells obtained (viability > 950%, and > 990% pure) were resuspended in Dulbecco's modified Eagle medium (DMEM) supplemented with 2 % (w/v) BSA, pH 7.4.
Culture of rat hepatocytes
Rat parenchymal cells, isolated according to the procedure of Seglen as described above, were cultured and seeded on 12-well culture plates (Costar) in Williams E medium containing 10% (v/v) foetal calf serum (Kuiper et al., 1989 NaOH and subsequently radioactivity and protein content were determined.
Studies in vitro with cultured parenchymal cells
Cultured parenchymal cells were transferred to 4 0C and washed twice with Williams E supplemented with 2 % BSA. Cells were incubated for 4 h with 10 ,g of 125I-labelled ,-VLDL/ml in the presence or absence of 300 ,g of unlabelled LDL/ml, or 3.6 nM-125I-labelled a2-macroglobulin, in medium supplemented with 2 % BSA. During the incubation the air was saturated with carbogen (95 % 02/5 % C02). After incubation the cells were washed three times with washing buffer and three times with washing buffer without BSA. Cells were lysed in 1 ml of 0.1 MNaOH, and radioactivity and protein content was determined.
Lipoprotein composition
Lipid composition of lipoproteins was determined using Boehringer enzymic kits for triacylglycerols (no. 701882 
RESULTS
Effect of lactoferrin on serum decay and liver uptake of chylomicrons, p8-VLDL and oc2-macroglobulin
The liver uptake and serum decay of chylomicrons are shown in Figs. 1(a) and 1(b) respectively. In accordance with earlier data the serum decay follows a characteristic pattern which is explained by extrahepatic processing of chylomicrons to chylomicron remnants by endothelial cell-bound lipoprotein lipase with subsequent uptake by the liver (Redgrave, 1970) . At 30 min after injection, 92 % of the injected dose is cleared from the circulation with 84 % of the injected dose recovered in the liver. Preinjection of 70 mg of lactoferrin/kg 1 min before injection of chylomicrons leads to a prolonged residence time of the chylomicron remnants as a consequence of a blockade of the liver uptake (at 5 min after injection only 9 % of the injected dose is recovered in the liver as compared with 26 % in the control). No significant difference in uptake by spleen and bone marrow was induced by lactoferrin (results not shown).
After injection of '25I-labelled ,J-VLDL into rats, the recognition by the liver is very fast. Preinjection of lactoferrin effectively blocks the liver uptake which leads to a prolonged residence time in the serum (Figs. Ic and ld). When a2-macroglobulin is treated with methylamine, it is converted into a substrate for the a2-macroglobulin receptor (Imber & Pizzo, 1981) . In accordance with the data of Feldman et al. (1983) the serum decay of the so-treated a2-macroglobulin is very rapid (t. approx. 2 min) whereby at 10 min after injection 86 % of the injected dose is recovered in the liver. At later timepoints, radioactivity in the liver decreases probably as a consequence of degradation, as was also observed by Davidson et al. (1985) for the a2-macroglobulin-trypsin complex. Similar kinetics have previously been reported, i.e. for asialofetuin (Ashwell & Morell, 1974) and tissue-type plasminogen activator (Kuiper et al., 1988 (Figs. 2a and 2b ).
The uptake of a2-macroglobulin by the liver is carried out in a more even way by the various cell types. Endothelial liver cells show the highest percentage of the injected dose/mg of cell protein leading, after taking into account their relatively low protein contribution to total liver (3.3 %), to an equal contribution of parenchymal and endothelial cells to total liver uptake ( Table 1) . Preinjection of lactoferrin does not affect the uptake of a2-macroglobulin by any of the cell types (Fig. 2c) .
Specific effect of lactoferrin on the remnant receptor versus the LDL receptor
To identify the receptor recognition system that is specifically influenced by lactoferrin, we analysed the effect of lactoferrin under conditions in which LDL receptors are up-regulated. Recognition of /-VLDL can then be observed by both the LDL receptor and the remnant receptor. Oestradiol treatment of rats results in a 17-fold increase in LDL receptors (Chao et al., 1979; Kovanen et al., 1979) , specifically on rat parenchymal cells (Harkes & van Berkel, 1983) .
In oestradiol-treated rats, the serum decay of/1-VLDL is faster than in control rats, while liver uptake of ,-VLDL is significantly higher at 10, 20 and 30 min after injection (Figs. 3a and 3b ). Under these conditions the effect of lactoferrin on the liver uptake and serum decay of /J-VLDL is clearly less pronounced than in control rats. The inhibition of liver uptake by lactoferrin in oestradiol-treated rats is 35% while this value is 92% for control rats (at 5 min after injection).
Injection of 1251I-labelled LDL into oestradiol-treated rats leads to rapid serum decay whereby at 5 min after injection 17.0 + 4.0 % of the injected dose of LDL is associated with the liver (control 2.1 + 0.2 %). As shown in Fig. 4 , lactoferrin has no effect on the uptake of 1251I-labelled LDL in oestradiol-treated rats. A direct comparison of the influence of lactoferrin on the initial liver uptake (determined 5 min after injection) illustrates the specificity of the effect of lactoferrin on uptake of chylomicron remnants and ,-VLDL in control rats (Fig. 4) . (Harkes et al., 1984a,b) , it was previously concluded that the remnant receptor is responsible for the interaction of ,-VLDL with these cell types (Harkes et al., 1989 ). The present competition experiments provide direct evidence that ,-VLDL and chylomicron remnants do compete for the same recognition site (Figs. 5a and 5b) . The experiments were performed at 37 'C instead of 4 'C, because the use of a physiological temperature is important for optimal lipoprotein-receptor interaction (Cooper et al., 1982) . A possible explanation for the temperature-dependence of chylomicron remnant binding to rat parenchymal cells in vitro may be a nonoptimal conformation of apoE as ligand for the remnant receptor as a consequence of the altered fluidity of shell phospholipids at low temperatures. It appears that ,J-VLDL is a very effective competitor for 251I-labelled chylomicron remnant association to parenchymal cells. The remnants themselves are also effective competitors, whereas LDL is essentially ineffective. Methylamine-activated a2-macroglobulin does not compete with 125I_ labelled chylomicron remnants for cell association.
With radioiodinated /?-VLDL as labelled ligand, similar competition curves were obtained to those with radioactive chylomicron remnants, indicating that chylomicron remnants and ,-VLDL compete for the same recognition site, whereas no competition is observed with LDL or a2-macroglobulin (Fig. Sb) .
In order to verify that the isolated parenchymal cells do express the specific high-affinity site for a2-macroglobulin, the cells were incubated with 125I-labelled a2-macroglobulin in the absence or presence of increasing concentrations of unlabelled a2-macroglobulin (Fig. 5c ). It appears that unlabelled a2-macroglobulin competes effectively with 125I-labelled a2-macroglobulin for cell association whereas both LDL and /J-VLDL are ineffective. [Competitor] (,ug/ml) receptor is diminished during the first 24 h of culture (Drevon et al., 1983 ). Feldman et al. (1985 reported that rat hepatocytes also exhibited a significant decrease in a2-macroglobulin receptor number during primary culture. A direct comparison of the regulation of the remnant and a2-macroglobulin receptor in culture (Fig. 6) 
DISCUSSION
The existence of a remnant receptor in liver is suppported by observations in patients with homozygous familial hypercholesterolaemia and WHHL rabbits in whom LDL receptors are genetically defective (Kita et al., 1982; Hoeg et al., 1985) . Both chylomicron remnants and large VLDL particles are rapidly cleared from the blood in these LDL-receptor-defective species, suggesting that a second (remnant) receptor may mediate such a clearance. Also, intravenous infusion of apoE into cholesterol-fed normal rabbits, who have down-regulated their LDL receptors, lowers plasma cholesterol concentration, suggesting that apoE may mediate the uptake of lipoproteins through pathways independent of the LDL receptor (Mahley et al., 1989 (Harkes & van Berkel, 1984a) , in contrast with cells from rabbits (Nenseter et al., 1988) or human parenchymal cells (Kleinherenbrink-Stins et al., 1991) , contain very few LDL receptors, which explains the total absence of competition by LDL. This conclusion is based on work with human LDL because this preparation can be obtained completely free of apoE (Harkes & van Berkel, 1984a) , which is important to prevent any interaction with the remnant receptor. Human LDL is readily recognized by oestrogen-induced LDL receptors in rats, so that an absence of competition cannot be explained by interspecies variation of LDL-receptor recognition. The clearance from the blood and liver association of ,-VLDL and chylomicron remnants in vivo is blocked by lactoferrin. When VLDL to the LDL receptor. Under these conditions the uptake of human LDL by liver is stimulated 8-fold, which indicates that human LDL is readily recognized by the induced LDL receptors and lactoferrin is totally ineffective in modifying this induced uptake. Herz et al. (1988) suggested that a high-M, protein (the LRP) might be an attractive candidate to function as the remnant receptor. Subsequently Kowal et al. (1989 Kowal et al. ( , 1990 , Lund et al. (1989) and Beisiegel et al. (1989) provided evidence that apoE might bind to LRP, although enrichment in vitro of f-VLDL with apoE was necessary to express binding. We showed earlier that the kinetics of binding of ,-VLDL to parenchymal cells in vivo (Harkes et al., 1989) and the properties of cell association in vitro do not indicate that additional apoE is needed for optimal interaction of ,3-VLDL with the remnant receptor on parenchymal cells. The debate over whether the remnant receptor is LRP has recently been intensified by the finding that the a2-macroglobulin receptor and LRP are the same molecule. Ten peptides derived from the a2-macroglobulin receptor by chemical or proteolytic digestion were sequenced and all appeared to be present within the cDNA-deduced structure of LRP (Strickland et al., 1990) . It is speculated that LRP is a multifunctional receptor with the capacity to bind diverse biological ligands. The present direct comparison of the characteristics of the a2-macroglobulin receptor and the remnant receptor in vivo and in vitro does not confirm this speculation. The following properties point to different sites for chylomicron remnants/fl-VLDL and a2-macroglobulin recognition.
1. In vivo, lactoferrin blocks specifically chylomicron remnant and fl-VLDL uptake by parenchymal cells, leaving a2-macroglobulin uptake unaffected. 2. Competition studies in vitro indicate that chylomicron remnants and ,-VLDL compete for the same recognition site whereas no mutual competition with the high-affinity site for a2-macroglobulin is observed.
Evidence that the recognition sites for chylomicron remnants/fl-VLDL and a2-macroglobulin reside on different molecules can be deduced from the following additional findings.
3. Recognition of the chylomicron/fl-VLDL particles is mainly by parenchymal cells whereas recognition of a2-macroglobulin is shared between parenchymal and endothelial cells. 4. A primary culture of liver parenchymal cells showed a significant decrease in a2-macroglobulin receptors whereas the recognition offl-VLDL by the remnant receptor is not influenced.
These four considerations provide conclusive evidence that the recognition sites for chylomicron remnants/,J-VLDL and a2-macroglobulin may reside in different parts of the receptor. Points 3 and 4 indicate that these sites reside on different molecules. As mentioned earlier, the tissue distribution of LRP does not coincide with the sites of chylomicron remnant/fl-VLDL uptake, as LRP is found nearly ubiquitously throughout animal cells (Herz et al., 1988) . Furthermore, for LRP, it was reported that Ca2+ is obligatory for binding of apoE-enriched fi-VLDL (Kowal et al., 1989) . Similar results concerning Ca2+ were reported for the ligand recognition of the a2-macroglobulin receptor (Moestrup et al., 1990 van Berkel, unpublished work) . When these additional two points are added to the four considerations mentioned above, we conclude that the remnant receptor of parenchymal cells, which recognizes both chylomicron remnants and fl-VLDL, possesses distinct properties and may not be identical with LRP. This conclusion suggests the need for further work to characterize the molecular nature of the remnant receptor. The availability of a non-lipoprotein competitive ligand (lactoferrin) for the remnant receptor might provide an important additional experimental tool.
